IEZZI, MANUELA
 Distribuzione geografica
Continente #
NA - Nord America 3.885
EU - Europa 3.470
AS - Asia 1.511
Continente sconosciuto - Info sul continente non disponibili 13
SA - Sud America 6
OC - Oceania 5
AF - Africa 3
Totale 8.893
Nazione #
US - Stati Uniti d'America 3.876
IE - Irlanda 706
CN - Cina 658
UA - Ucraina 597
IT - Italia 542
SE - Svezia 478
TR - Turchia 457
GB - Regno Unito 362
FR - Francia 247
IN - India 241
DE - Germania 216
FI - Finlandia 123
RU - Federazione Russa 103
SG - Singapore 90
CZ - Repubblica Ceca 36
VN - Vietnam 31
BE - Belgio 25
IR - Iran 13
EU - Europa 12
NL - Olanda 11
GR - Grecia 7
HK - Hong Kong 7
CA - Canada 6
IL - Israele 4
RO - Romania 4
AT - Austria 3
AU - Australia 3
CH - Svizzera 3
CL - Cile 3
MY - Malesia 3
BR - Brasile 2
JP - Giappone 2
NZ - Nuova Zelanda 2
PL - Polonia 2
PT - Portogallo 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BG - Bulgaria 1
CY - Cipro 1
EG - Egitto 1
ES - Italia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MX - Messico 1
NO - Norvegia 1
NP - Nepal 1
PA - Panama 1
PK - Pakistan 1
PR - Porto Rico 1
PY - Paraguay 1
SC - Seychelles 1
SN - Senegal 1
Totale 8.893
Città #
Chandler 901
Jacksonville 704
Dublin 696
Princeton 300
Southend 286
Dearborn 233
Izmir 224
Nanjing 183
Ann Arbor 155
Beijing 146
Ashburn 141
Altamura 134
Wilmington 134
Chieti 114
Cambridge 111
Boardman 99
New York 77
Nanchang 63
Singapore 55
Woodbridge 50
Hebei 34
Grevenbroich 33
Dong Ket 31
Washington 30
Shenyang 29
Tianjin 29
Brno 28
Helsinki 27
Kunming 24
Rome 24
Norwalk 23
Changsha 21
Seattle 21
Brussels 20
Jiaxing 18
Los Angeles 18
Hangzhou 16
San Mateo 16
Augusta 14
Jinan 14
Orange 14
Falls Church 13
Milan 13
Houston 12
London 12
Pune 12
Leawood 11
Pescara 11
Chicago 10
Ardabil 9
Changchun 9
Lanzhou 9
Napoli 9
Verona 9
Guangzhou 8
Hefei 8
Amsterdam 7
Collecorvino 7
Lanciano 7
Olomouc 7
Ancona 6
Hong Kong 6
L’Aquila 6
Munich 6
Rouen 6
Saint-Saens 6
Taizhou 6
Frankfurt am Main 5
Monmouth Junction 5
San Giovanni 5
Senigallia 5
Tappahannock 5
Torino 5
Toronto 5
Zhengzhou 5
Andover 4
Bari 4
Fuzhou 4
Jülich 4
L'aquila 4
Palermo 4
Redwood City 4
San Diego 4
Auburn Hills 3
Bologna 3
Cachan 3
Castelletto Stura 3
Catania 3
Ferrara 3
Haikou 3
Kuala Lumpur 3
Lappeenranta 3
Lucca 3
Mcallen 3
Naples 3
Nereto 3
Ningbo 3
Redmond 3
Sydney 3
Vienna 3
Totale 5.638
Nome #
Resolvin D1 enhances the resolution of lung inflammation caused by long-term Pseudomonas aeruginosa infection 124
Biofilm formation by the emerging fungal pathogen Trichosporon asahii: development, architecture, and antifungal resistance. 107
ALK protein analysis by IHC staining after recent regulatory changes: A comparison of two widely used approaches, revision of the literature, and a new testing algorithm 106
EV20-mediated delivery of cytotoxic auristatin MMAF exhibits potent therapeutic efficacy in cutaneous melanoma 95
EV20-Sap, a novel anti-HER-3 antibody-drug conjugate, displays promising antitumor activity in melanoma 92
Feasibility of telomerase-specific adoptive T-cell therapy for B-cell chronic lymphocytic leukemia and solid malignancies 92
Functional and prognostic significance of the genomic amplification of frizzled 6 (FZD6) in breast cancer 90
Activated d16HER2 homodimers and SRC kinase mediate optimal efficacy for trastuzumab. 89
A DNA vaccine targeting angiomotin inhibits angiogenesis and suppresses tumor growth. 89
Autoimmune B cell lymphopenia following successful adoptive therapy with telomerase-specific T lymphocytes. 88
Sorafenib's inhibition of prostate cancer growth in transgenic adenocarcinoma mouse prostate mice and its differential effects on endothelial and pericyte growth during tumor angiogenesis. 87
A limited autoimmunity to p185neu elicited by DNA and allogeneic cell vaccine hampers the progression of preneoplastic lesions in HER-2/NEU transgenic mice. 86
Phenylmethimazole reverses plasminogen activator inhibitor-1 (PAI-1) overexpression in diabetic rats 86
Phage-Based Anti-HER2 Vaccination Can Circumvent Immune Tolerance against Breast Cancer 86
The expression of LEC/CCL16, a powerful inflammatory chemokine, is upregulated in ulcerative colitis. 85
Reversal of P-glycoprotein-mediated multidrug resi stance in human sarcoma MES-SA/Dx-5 cells by nonsteroidal anti-inflammatory drugs 85
Effect of maternal exposure to endocrine disrupting chemicals on reproduction and mammary gland development in female sprague-dawley rats. 84
Effects of chronic hypoxia and cobalt on macroprotein pattern in the rabbit carotid body and superior cervical ganglion: preliminary observations. 84
Resveratrol fuels HER2 and ERα-positive breast cancer behaving as proteasome inhibitor 84
Xenogeneic immunization in mice using HER2 DNA delivered by an adenoviral vector. 83
Anti-Thyroid Effect of Resveratrol 83
Resveratrol has anti-thyroid effects both in vitro and in vivo 83
HCG hastens both the development of mammary carcinoma and the metastatization of HCG/LH and ERBB-2 receptor-positive cells in mice. 82
BALB-neuT Female Mice as a Dynamic Model of Mammary Cancer 82
Inhibition of prostate carcinogenesis by combined active immunoprophylaxis 80
Tamoxifen combined to anti-HER-2/neu cell vaccine does not hamper cancer immunopreventive efficacy. 79
Class II phosphoinositide 3-kinase C2β regulates a novel signaling pathway involved in breast cancer progression 79
Dramatic response to crizotinib in ROS1 fluorescent in situ hybridization- and immunohistochemistry-positive lung adenocarcinoma: a case series. 78
Vaccines against human HER2 prevent mammary carcinoma in mice transgenic for human HER2 78
A DNA Vaccine against ERBB2 Impairs Chemical Carcinogenesis in Random-Bred Hamsters. 77
MiR-205-5p inhibition by locked nucleic acids impairs metastatic potential of breast cancer cells 77
PLC-gamma-1 phosphorylation status is prognostic of metastatic risk in patients with early-stage Luminal-A and -B breast cancer subtypes 77
Cure of mammary carcinomas in Her-2 transgenic mice through sequential stimulation of innate (neoadjuvant interleukin-12) and adaptive (DNA vaccine electroporation) immunity. 76
A better immune reaction to Erbb-2 tumors is elicited in mice by DNA vaccines encoding rat/human chimeric proteins. 76
Effective control of acute myeloid leukaemia and acute lymphoblastic leukaemia progression by telomerase specific adoptive T-cell therapy 76
The non-inflammatory role of C1q during Her2/neu-driven mammary carcinogenesis 76
Salivary carcinoma in HER-2/neu transgenic male mice: an angiogenic switch is not required for tumor onset and progression 75
AvidinOX for highly efficient tissue-pretargeted radionuclide therapy. 75
Preventive Vaccination with Telomerase Controls Tumor Growth in Genetically Engineered and Carcinogen-Induced Mouse Models of Cancer. 74
Antitumor immunization of mothers delays tumor development in cancer-prone offspring 74
Analytical assessment of MALDI-TOF Imaging Mass Spectrometry on thin histological samples. An insight in proteome investigation. 74
The water soluble ruthenium(II) organometallic compound [Ru(p-cymene)(bis(3,5 dimethylpyrazol-1-yl)methane)Cl]Cl suppresses triple negative breast cancer growth by inhibiting tumor infiltration of regulatory T cells 74
Electroporated DNA Vaccine Clears Away Multifocal Mammary Carcinomas in Her-2/neu Transgenic Mice 74
HARNESSING RESOLUTION MEDIATORS AS NOVEL THERAPEUTICS FOR CYSTIC FIBROSIS 74
Repurposing a psychoactive drug for children with cancer: p27 Kip1-dependent inhibition of metastatic neuroblastomas by Prozac 74
Resolvin D1 promotes resolution of inflammation, infection, and damage in CF 74
Sanguinarine suppresses basal-like breast cancer growth through dihydrofolate reductase inhibition. 73
Timely DNA vaccine combined with systemic IL-12 prevents parotid carcinomas before a dominant-negative p53 makes their growth independent of HER-2/neu expression. 73
An integrated approach of immunogenomics and bioinformatics to identify new Tumor Associated Antigens (TAA) for mammary cancer immunological prevention. 72
Neutrophils in anti-cancer immunological strategies: old players in new games 72
RESOLVIN D1 FOR TARGETING LUNG INFLAMMATION, INFECTION, AND DAMAGE IN CF 72
Decreased expression of the plasminogen activator inhibitor-1 (PAI-1) gene in diabetic rats treated with phenylmethimazole 71
Effects of castration on the development of prostate adenocarcinoma from its precursor HGPIN and on the occurrence of androgen-independent poorly differentiated carcinoma in TRAMP mice. 70
Multiple roles of perforin in hampering ERBB-2 (Her-2/neu) carcinogenesis in transgenic male mice 70
The adjuvant activity of BAT antibody enables DNA vaccination to inhibit the progression of established autochthonous Her-2/neu carcinomas in BALB/c mice. 69
Immunoprevention of HER-2/neu transgenic mammary carcinoma through an interleukin 12-engineered allogeneic cell vaccine. 69
Immunoprevention of mammary carcinoma in HER-2/neu transgenic mice is IFN-gamma and B cell dependent. 69
Effect of acute and chronic cobalt administration on carotid body chemoreceptors responses. 69
A Dietary Tomato Supplement Prevents Prostate Cancer in TRAMP Mice 69
HER-2/neu mediates oncogenic transformation via altered CREB expression and function. 69
Inhibition of the Phosphatidylinositol 3-kinase/Akt Pathway by Inositol Pentakisphosphate Results in Antiangiogenic and Antitumor Effects. 69
Lack of expression of galectin-3 is associated with a poor outcome in node-negative patients with laryngeal squamous-cell carcinoma. 68
A multi-DNA preventive vaccine for p53/Neu driven cancer syndrome. 68
The scaffold protein p140Cap limits ERBB2-mediated breast cancer progression interfering with Rac GTPase-controlled circuitries 68
Predictive signatures inform the effective repurposing of Decitabine to treat K-RAS-dependent Pancreatic Ductal Adenocarcinoma 68
ACTIONS OF RESOLVIN D1 AND D2 IN CYSTIC FIBROSIS MRSA LUNG INFECTION AND INFLAMMATION 68
Stem Cell Emergence After HBO In Volunteers 67
Quercetin increases Major Histocompatibility Complex (MHC) class I expression in thyroid cells 67
Prevention by delay: nonspecific immunity elicited by IL-12 hinders Her-2/neu mammary carcinogenesis in transgenic mice. 66
p130Cas is an essential transducer element in ErbB2 transformation. 66
LAG-3 enables DNA vaccination to persistently prevent mammary carcinogenesis in HER-2/neu transgenic BALB/c mice. 66
A vaccine targeting angiomotin induces an antibody response which alters tumor vessel permeability and hampers the growth of established tumors. 65
Computational drugs repositioning identifies inhibitors of oncogenic PI3K/AKT/P70S6K-dependent pathways among FDAapproved compounds 65
Irreversible inhibition of Δ16HER2 is necessary to suppress Δ16HER2-positive breast carcinomas resistant to Lapatinib 65
Protective immunity against neu-positive carcinomas elicited by electroporation of plasmids encoding decreasing fragments of rat neu extracellular domain. 64
Cutting Edge: TRAIL Deficiency Accelerates Hematological Malignancies. 64
Development of rhabdomyosarcoma in HER-2/neu transgenic p53 mutant mice. 64
Phospholipase Cgamma1 is required for metastasis development and progression 63
Intramammary application of non-methylated-CpG oligodeoxynucleotides (CpG) inhibits both local and systemic mammary carcinogenesis in female BALB/c Her-2/neu transgenic mice. 63
Antimetastatic activity of a preventive cancer vaccine. 63
Inhibition of mammary carcinoma development in HER-2/neu transgenic mice through induction of autoimmunity by xenogeneic DNA vaccination. 63
Interleukin-15 is required for immunosurveillance and immunoprevention of HER2/neu-driven mammary carcinogenesis 63
Pathobiological implications of the d16HER2 splice variant for stemness and aggressiveness of HER2-positive breast cancer 63
Monomeric allergoid intragastric administration induces local and systemic tolerogenic response involving IL-10-producing CD4(+)CD25(+) T regulatory cells in mice. 63
Intradermal DNA Electroporation Induces Cellular and Humoral Immune Response and Confers Protection against HER2/neu Tumor 63
Triggering CD40 on endothelial cells contributes to tumor growth. 62
Gene expression analysis of immune-mediated arrest of tumorigenesis in a transgenic mouse model of HER-2/neu-positive basal-like mammary carcinoma. 62
EFFECTS OF HYPERBARIC OXYGEN EXPOSURE ON MOBILIZATION OF ENDOTHELIAL PROGENITOR CELLS IN HEALTHY VOLUNTEERS 62
Effects of ELF-EMF exposure on haemopoiesis and mammary carcinogenesis in BALB/c mice 61
L’allergoide monomerico agisce anche sul GALT 61
Flavonoids inhibit melanoma lung metastasis by impairing tumor cells endothelium interactions. 60
Host perforin reduces tumor number but does not increase survival in oncogene-driven mammary adenocarcinoma. 60
Zoledronic acid repolarizes tumour-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway. 60
Expression of CREB in Primary Pterygium and Correlation with Cyclin D1, ki-67, MMP7, p53, p63, Survivin and Vimentin. 60
HER2 isoforms co-expression differently tunes mammary tumor phenotypes affecting onset, vasculature and therapeutic response 60
Immunosurveillance of Erbb2 carcinogenesis in transgenic mice is concealed by a dominant regulatory T-cell self-tolerance. 59
The Human Splice Variant Δ16HER2 Induces Rapid Tumor Onset in a Reporter Transgenic Mouse. 59
Imaging DNA damage allows detection of preneoplasia in the BALB-neuT model of breast cancer 59
Disruption of IFN-I signaling promotes HER2/neu tumor progression and breast cancer stem cells 59
Phenethyl isothiocyanate hampers growth and progression of HER2-positive breast and ovarian carcinoma by targeting their stem cell compartment 59
Totale 7.345
Categoria #
all - tutte 35.117
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.117


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.749 474 122 10 60 147 160 227 148 55 157 166 23
2020/2021932 135 17 150 12 88 165 27 10 58 115 90 65
2021/2022708 14 14 14 120 53 12 26 60 55 50 83 207
2022/20232.483 184 362 156 282 274 472 128 169 287 33 68 68
2023/20241.187 79 54 73 55 64 351 271 67 14 30 15 114
2024/2025162 162 0 0 0 0 0 0 0 0 0 0 0
Totale 9.420